Augmentin Dosing for a 56-lb Child with Left AOM
For a 56-lb (25 kg) child with left acute otitis media, prescribe Augmentin 90 mg/kg/day of amoxicillin component (2,250 mg total daily) divided into two doses (1,125 mg twice daily) for 10 days, using the high-dose formulation (Augmentin ES-600 or equivalent 14:1 ratio formulation). 1, 2
Rationale for High-Dose Augmentin
The 2013 AAP/AAFP guidelines recommend amoxicillin-clavulanate (rather than amoxicillin alone) when the child has received amoxicillin in the past 30 days, has concurrent purulent conjunctivitis, or has recurrent AOM unresponsive to amoxicillin 1. Even for first-line treatment, high-dose amoxicillin-clavulanate (90 mg/kg/day) provides superior coverage against β-lactamase-producing organisms (H. influenzae, M. catarrhalis) and penicillin-resistant S. pneumoniae that commonly cause treatment failures 2, 3.
Specific Dosing Calculation
- Weight: 56 lbs = 25.4 kg
- Dose: 90 mg/kg/day amoxicillin = 2,286 mg/day ≈ 2,250 mg/day (practical rounding)
- Divided dose: 1,125 mg twice daily
- Duration: 10 days 2
Why This Dose Matters
The FDA label data demonstrates that Augmentin ES-600 (90/6.4 mg/kg/day) achieved 98.4% bacteriologic eradication for S. pneumoniae overall, including 85.7% eradication for penicillin-resistant strains (MIC = 4 mcg/mL) 2. Clinical success rates at 2-4 days post-therapy were 89.1% for S. pneumoniae and 87.0% for H. influenzae 2.
The high-dose formulation uses a 14:1 ratio (amoxicillin:clavulanate) rather than the conventional 7:1 or 4:1 ratios. This provides adequate amoxicillin for resistant organisms while minimizing clavulanate-related diarrhea 2, 4. Studies show protocol-defined diarrhea occurs in only 11-13% of children on high-dose formulations versus 26% on conventional doses 2, 5.
Clinical Context: When to Use This Regimen
Use high-dose Augmentin (90 mg/kg/day) for:
- Any child with AOM requiring β-lactamase coverage (per guideline indications above) 1
- Children under 2 years with bilateral AOM (though this child has unilateral disease) 1
- Geographic areas with high rates of resistant S. pneumoniae 2
Important Caveat for Unilateral AOM in Older Children
Since this is a unilateral (left) AOM in what appears to be an older child (56 lbs suggests age >4 years), the AAP guidelines actually support either antibiotic treatment OR observation with close follow-up based on shared decision-making with parents 1. However, if the decision to treat has been made:
- If severe signs/symptoms present (moderate-severe otalgia >48 hours OR temperature ≥39°C): Definitely treat with antibiotics 1
- If non-severe: Observation is acceptable alternative with 48-72 hour follow-up 1
Practical Prescribing
Formulation options:
- Augmentin ES-600: 600 mg/5 mL suspension (provides 600 mg amoxicillin per 5 mL)
- Dose: 9.4 mL twice daily
- Alternative: Augmentin 875/125 mg tablets if child can swallow pills
- Dose: 1.5 tablets twice daily (not ideal due to pill burden)
Reassessment: Instruct parents to return if symptoms worsen or fail to improve within 48-72 hours, as this indicates potential treatment failure requiring regimen change 1.
Evidence Strength
The recommendation prioritizes FDA drug label data 2 showing superior bacteriologic and clinical outcomes with high-dose formulations, supported by AAP/AAFP Grade B-C recommendations 1. Recent 2024 data confirms amoxicillin-based regimens remain effective despite increasing β-lactamase-producing bacteria prevalence (65.8% in one cohort), with only 5.4% treatment failure rates 6. A 2023 systematic review concluded amoxicillin-clavulanate should be the treatment of choice for pediatric AOM 7.
Common pitfall: Underdosing is prevalent (89% of prescriptions in one study) and correlates with poor outcomes specifically in children <20 kg with bilateral AOM 8. While this child is >20 kg with unilateral disease, high-dose therapy remains appropriate given superior pathogen coverage and comparable tolerability 2, 4.